Market cap:
IMM - $250m
IMU - $1.3b
7 years ago IMU - $10m m/c.
We have been left behind by our peers (not only IMU) on the clinical development front.
Pipeline in a product and Lag pure play obviously doesn't wash in the eyes of market.
AIPAC - agreed with poster 'China partner to develop'
NSCLC and HNC - favourites to develop. But what's the end game - Merck would hold all ace cards and really don't need to over commit- supply agreements keep efti in trials possibly ad-infinitum?
Where's the competitive tension?
Maybe I'm missing something here but not 'feeling the love' or advisory on strategic direction and comms have been p poor of late.
Also poor form imo for chairman to dismiss share price decline to purely geopolitical and other external issues.
I don't want fluff. Take responsibility.
IMM vs IMU, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 121215 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2864 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |